Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  valspodar
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065178, E-1A95, CAN-NCIC-MY8, CLB-E1A95, EORTC-E1A95/06971, SWOG-E1A95, CAN-NCIC-J1A95, CLB-9596, SWOG-S1A95, MY8, NCT00002878

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: E-2995, E2995

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02793, CALGB-9720, U10CA031946, CLB-9720, NCT00003190

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: LRF-AML14, EU-20016, NCT00005823, ISRCTN62207270

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI
Protocol IDs: NCI-2012-02824, CALGB-19808, U10CA031946, NCT00006363

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 17 and over
Sponsor:
Protocol IDs: MDA-DM-94052, NCI-V95-0604

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI
Protocol IDs: CDR0000065333, U10CA031946, CLB-9621, CALGB-9621, NCT00002925

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-97-C-0074C, NCI-T96-0011, T96-0011

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-126E

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065011, E-1195, NCT00002826

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MAYO-943001, NCI-V96-1077

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000065380, U01CA063265, CHNMC-96002, NCI-H97-1137, NCT00002937

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 56 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067450, S9918, U10CA032102, SWOG-S9918, NCT00004217

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: NCI-94-C-0119I, NCI-MB-330, NCI-T93-0123N, T93-0123

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: CLB-9420, CALGB-9420

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: WU-95-0718, NCI-T93-0034O, T93-0034

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 56 and over
Sponsor: NCI
Protocol IDs: SWOG-S9617, SWOG-9617, S9617

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 22 at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01835, POG-9423, CCG-P9423, CDR0000065285, P9423, NCT00002912

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSGCC-9604, NCI-T96-0066, T96-0066

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066062, WU-106, NCI-T97-0073, T97-0073, NCT00003207

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: NCI-92-C-0268K, NCI-T92-0100N, NCI-MB-288
New Search